Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report
Er Hong, Xi-Er Chen, Jia Mao, Jingjing Zhou et autres
BACKGROUND: The emergence of secondary drug resistance when treating epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) using EGFR-tyrosine kinase inhibitors (EGFR-TKIs), seriously affects the therapeutic efficacy and survival of patients. Here, we report a case of advanced NSCLC …
cn (code pays fourni par la source)
3 citations
World Journal of Clinical Cases